Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs cimetidine for prevention of clinically significant upper GI bleeding in critically ill patients
CTR20140431Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in upper gastrointestinal bleeding (UGIB), sponsored by AstraZeneca. Started Jun 2014; status: completed.
02
Drugs
esomeprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on CTR20140431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140431.